Skip to main content
Signal8

BOSTON SCIENTIFIC CORP (BSX) Form 8-K — Nov 17, 2026

$BSXForm 8-KItems 5.02, 8.01, 9.01Filed Nov 17, 2026, 4:08 PM ET0000885725-26-000073Original filing

Boston Scientific's board approved its 2027 Annual Bonus Plan and two 2027 performance share programs on November 17, 2026, all substantially similar to the 2026 versions. The bonus plan pays 0%-225% of target based on Global Sales and Adjusted EPS metrics, with a quality-based downward discretion retained by the Compensation Committee. The three-year performance share programs (2027-2029) tie executive RSU vesting to relative TSR versus the S&P 500 Healthcare Index (0%-200% payout) and to organic net sales growth versus the financial plan, both subject to Dodd-Frank clawback provisions. Separately, David S.

Key figures

Performance period
January 1, 2027 - December 31, 2029
Max individual payout
0%-225% of target bonus
Dynamic bonus pool cap
10% of target bonus pool
Performance share payout range
0%-200% of target
Bonus distribution percentage range
0%-150%

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    BOSTON SCIENTIFIC CORP (BSX) Form 8-K — Nov 17, 2026: AI Analysis | Signal8